This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gardiner, J. Articles by Kupersmith, J. Search for Related Content PubMed PubMed Citation Articles by Gardiner, J. Articles by Kupersmith, J. Social Bookmarking                   What's this?

Confidence Intervals for Cost - Effectiveness Ratios

Andrew Hogan, PhD

Margaret Holmes-Rovner, PhD

David Rovner, MD

Lawrence Griffith, MD

Joel Kupersmith, MD

The problem of variability in computed cost-effectiveness ratios (CERs) is usually addressed by performing sensitivity analyses to determine the effects on these ratios of plausible ranges of values of input parameters. However, the sampling variation that exists in these estimated parameters can be utilized to obtain confidence intervals for cost-effectiveness ratios. As cost-effectiveness analysis becomes more widely used, new techniques need to be de veloped for establishing when a difference in strategies evaluated is meaningful. A first step is to establish the precision of the CER itself. The authors estimate the precision of a CER in the context of a statistical model in which the primary outcome is survival, with cost and effectiveness defined in terms of the underlying survival distribution (S). Effectiveness () is measured by life expectancy, restricted to a finite time horizon and discounted at a fixed rate r, = e-^rtS(t)dt. Cumulative cost (ß) per patient is regarded as resource utilization and incurred randomly over time depending on the survival experience of the patient, p = e - ^rtS(t)dC(t), where C(t) is the total potential resources utilized up to time t. Average cost effectiveness (ACE) of a single strategy is ß/, and when comparing two strategies, the CER is ß/, the ratio of the incremental cost to the difference in mean survival. Utilizing the sampling distribution of the Kaplan-Meier estimate of S yields standard errors and confidence intervals for ACE and CER. The technique is applied to survival data from 218 previously studied patients to assess 95% confidence intervals for the CER and ACE of the implantable cardioverter defibrillator as compared with electrophysiology-guided therapy. Key words: cost-effectiveness analysis; sensitivity analysis; Kaplan-Meier estimate; av erage cost-effectiveness; cardioverter defibrillator; survival data. (Med Decis Making 1995;15:254-263)

Medical Decision Making, Vol. 15, No. 3, 254-263 (1995)
DOI: 10.1177/0272989X9501500308


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. P. Johnson-Masotti, P. W. Laud, R. G. Hoffmann, M. J. Hayat, and S. D. Pinkerton A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention Med Decis Making, November 1, 2004; 24(6): 634 - 653. [Abstract] [PDF]

				G Parmigiani Measuring uncertainty in complex decision analysis models Statistical Methods in Medical Research, December 1, 2002; 11(6): 513 - 537. [Abstract] [PDF]

				G. Blackhouse, A. H. Briggs, and B. J. O'Brien A Note on the Estimation of Confidence Intervals for Cost-Effectiveness When Costs and Effects Are Censored Med Decis Making, April 1, 2002; 22(2): 173 - 177. [Abstract] [PDF]

				A. I. Mushlin, W. J. Hall, J. Zwanziger, E. Gajary, M. Andrews, R. Marron, K. H. Zou, and A. J. Moss The Cost-effectiveness of Automatic Implantable Cardiac Defibrillators: : Results From MADIT Circulation, June 2, 1998; 97(21): 2129 - 2135. [Abstract] [Full Text] [PDF]

				J. Lipscomb, M. Ancukiewicz, G. Parmigiani, V. Hasselblad, G. Samsa, and D. B. Matchar Predicting the Cost of Illness: A Comparison of Alternative Models Applied to Stroke Med Decis Making, April 1, 1998; 18(2): S39 - S56. [Abstract] [PDF]

				G. Parmigiani, G. P. Samsa, M. Ancukiewicz, J. Lipscomb, V. Hasselblad, and D. B. Matchar Assessing Uncertainty in Cost-Effectiveness Analyses: Application to a Complex Decision Model Med Decis Making, October 1, 1997; 17(4): 390 - 401. [Abstract] [PDF]